Evidence map›Paper›PMID 37640941›Full record

ArticleMolecular imaging and biology2024

The Balance Between the Therapeutic Efficacy and Safety of [

Marjolein Verhoeven, Joost Haeck, Erik de Blois, Francesca Orlandi, Donato Barbato, Mattia Tedesco, Mark Konijnenberg, Simone U Dalm

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular imaging and biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. RM2 and DB15 analogues bearing [EJNMMI radiopharmacy and chemistry · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Marjolein VerhoevenDepartment of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, 3015 GD, Rotterdam, The Netherlands.
Joost HaeckDepartment of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, 3015 GD, Rotterdam, The Netherlands.
Erik de BloisDepartment of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, 3015 GD, Rotterdam, The Netherlands.
Francesca OrlandiAdvanced Accelerator Applications, a Novartis Company, 10010, Colleretto Giacosa, Italy.
Donato BarbatoAdvanced Accelerator Applications, a Novartis Company, 10010, Colleretto Giacosa, Italy.
Mattia TedescoAdvanced Accelerator Applications, a Novartis Company, 10010, Colleretto Giacosa, Italy.
Mark KonijnenbergDepartment of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, 3015 GD, Rotterdam, The Netherlands.
Simone U DalmDepartment of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, 3015 GD, Rotterdam, The Netherlands. s.dalm@erasmusmc.nl.ORCID 0000-0002-6393-6901
Erasmus MC · NLNovartis (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRadiolabeled NeoB is a promising gastrin-releasing peptide receptor (GRPR)-targeting radiopharmaceutical for theranostics of GRPR-expressing malignancies, e.g., prostate cancer (PCa). The aim of this study was to evaluate the effect of different doses of [ PROCEDURES: To determine the efficacy of [

resultsTreatment of PC-3 tumors with all three studied [

conclusionsTreatment with [

Indexed as

Prostatic NeoplasmsRadioisotopesAnimalsCell Line, TumorHumansMaleMiceProstateReceptors, BombesinRadioisotopesReceptors, Bombesin[177Lu]Lu-NeoBEfficacyGastrin-releasing peptide receptor (GRPR)Prostate cancerTheranosticsToxicity

Identifiers

PMID37640941
PMCPMC10828073
OpenAlexW4386212151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.